| abstract |
Disclosed is a drug for the treatment of a condition characterized by the formation and accumulation of advanced glycation end products (AGE). Use of a compound represented by formula (I). In the formula (I), n and o are 0, 1, or 2; x is an integer of 2 to 25000; R1, R2, R3, and R4 are each independently a polymer, —Rx-polymer R5 and R6 are each independently H, alkyl, heteroalkyl, and the like. [Selection figure] None |